Financhill
Back

Cue Biopharma Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
54

CUE
Cue Biopharma

Last Price:
1.37
Seasonality Move:
22.34%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Cue Biopharma Price Quote

$1.37
-0.12 (-7.74%)
(Updated: November 5, 2024 at 9:35 AM ET)

Cue Biopharma Key Stats

Buy
54
Cue Biopharma (CUE) is a Buy

Day range:
$1.45 - $1.64
52-week range:
$0.45 - $3.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
8.65
P/B ratio:
4.14%

Volume:
425.6K
Avg. volume:
1.1M
1-year change:
-39.39%
Market cap:
$89.4M
Revenue:
$5.5M
EPS:
$-0.98

How Much Does Cue Biopharma Make?

Is Cue Biopharma Growing As A Company?

  • What Is Cue Biopharma's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.92%
  • What Is Cue Biopharma's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Cue Biopharma Stock Price Performance

  • Did Cue Biopharma Stock Go Up Last Month?
    Cue Biopharma share price went up by 28.02% last month
  • Did CUE's Share Price Rise Over The Last Year?
    CUE share price fell by -39.39% over the past 1 year

What Is Cue Biopharma 52-Week High & Low?

Cue Biopharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cue Biopharma?

  • How Much Debt Does Cue Biopharma Have?
    Total long term debt quarterly is $6.2M
  • How Much Cash Does Cue Biopharma Have?
    Cash and short term investments quarterly total is $30M
  • What Is Cue Biopharma’s Book Value Per Share?
    Book value per share is 0.44

Is Cue Biopharma Cash Flow Positive?

  • What Is CUE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$38.5M
  • What Is Cue Biopharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10.7M
  • What Is Cue Biopharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $4.9M

Cue Biopharma Return On Invested Capital

  • Is Management Doing A Good Job?
    CUE return on invested capital is -107.58%
  • What Is Cue Biopharma Return On Assets?
    ROA measures how assets are converting to revenues and is -78.3%
  • What Is CUE Return On Equity?
    ROE is a measure of profitability and is -132.34%

Cue Biopharma Earnings Date & Stock Price

  • What Is Cue Biopharma's Stock Price Today?
    A single share of CUE can be purchased today for 1.49
  • What Is Cue Biopharma’s Stock Symbol?
    Cue Biopharma trades on the nasdaq under the ticker symbol: CUE
  • When Is Cue Biopharma’s Next Earnings Date?
    The next quarterly earnings date for Cue Biopharma is scheduled on November 8, 2024
  • When Is CUE's next ex-dividend date?
    Cue Biopharma's next ex-dividend date is May 26, 2020
  • How To Buy Cue Biopharma Stock?
    You can buy Cue Biopharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Cue Biopharma Competitors

  • Who Are Cue Biopharma's Competitors?
    Below is a list of companies who compete with Cue Biopharma or are related in some way:
    • Arbutus Biopharma Corp (ABUS)
    • Biomarin Pharmaceutical Inc (BMRN)
    • Cidara Therapeutics Inc (CDTX)
    • FibroGen Inc (FGEN)
    • GlycoMimetics Inc (GLYC)

Cue Biopharma Dividend Yield

Cue Biopharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 28.57%
Revenue: 92.33% 106.21%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 4.00
Upside from Last Price: 169.36%

Major Shareholders

  • How many CUE shares are owned by institutional investors?
    16.6M CUE shares are owned by institutional investors
  • How many CUE shares are owned by insiders?
    2.2M CUE shares are owned by insiders